Showing results (61-70 of 109) with videos related to
Sort By:
Pageof 11
Cancer|June 15, 2007
Correlates of screening sigmoidoscopy use among men in a large nonprofit health planReina Haque, Virginia P Quinn, Laurel A Habel, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 22, 2009
Breast cancer recurrence in older women five to ten years after diagnosisJaclyn L F Bosco, Timothy L Lash, Marianne N Prout, et al.Plos One|January 22, 2010
Prostatitis, sexually transmitted diseases, and prostate cancer: the California Men's Health StudyIona Cheng, John S Witte, Steven J Jacobsen, et al.Cancer Causes & Control : CCC|July 17, 2012
Validation of AJCC TNM staging for breast tumors diagnosed before 2004 in cancer registriesMarilyn L Kwan, Reina Haque, Valerie S Lee, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2009
Adherence to long-term surveillance mammography among women with ductal carcinoma in situ treated with breast-conserving surgeryLarissa Nekhlyudov, Laurel A Habel, Ninah S Achacoso, et al.The American Journal of Managed Care|November 10, 2009
Correlates of prostate-specific antigen testing in a large multiethnic cohortReina Haque, Stephen K Van Den Eeden, Steven J Jacobsen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2015
A comparative study of molecular characteristics of diffuse large B-cell lymphoma from patients with and without human immunodeficiency virus infectionChun Chao, Michael J Silverberg, Lanfang Xu, et al.AIDS (London, England)|September 11, 2015
Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survivalChun Chao, Lanfang Xu, Michael J Silverberg, et al.Future Oncology (London, England)|December 23, 2025
Utilization of extended-interval, fixed-dosing of durvalumab, every 4 weeks, in U.S. patients with unresectable stage III NSCLC following concurrent chemoradiationReina Haque, Eric McGary, Mike Z Yang, et al.The Journal of Urology|February 22, 2011
Regular nonsteroidal anti-inflammatory drug use and erectile dysfunctionJoseph M Gleason, Jeffrey M Slezak, Howard Jung, et al.Pageof 11